Nurse Practitioner, Family · Los Angeles, CA
NPI
1205155447
Since 2010
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1700 Cesar Chavez Ave, Suite 3900
Los Angeles, CA, 90033
Phone (323) 307-0800
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.3M
5,404 prescriptions
Company payments, 2025
$12K
From 25 companies
Medicare prescription drug claims, 2024
In 2024, the drug Karla I Menjivar prescribed most often to Medicare patients was Kerendia (Finerenone), with 669 prescriptions and refills. In total Karla I Menjivar wrote 5,404 Medicare prescriptions that cost $2.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Kerendia Finerenone | 669 | 697 | 101 | $424K |
| Farxiga Dapagliflozin Propanediol | 374 | 424 | 74 | $228K |
| Repatha Sureclick Evolocumab | 267 | 271 | 40 | $140K |
| Rybelsus Semaglutide | 218 | 236 | 40 | $209K |
| Lokelma Sodium Zirconium Cyclosilicate | 214 | 252 | 38 | $180K |
| Jardiance Empagliflozin | 196 | 214 | 36 | $120K |
| Atorvastatin Calcium Generic | 183 | 371 | 60 | $873 |
| Losartan Potassium Generic | 173 | 357 | 56 | $990 |
| Febuxostat Generic | 171 | 184 | 25 | $11K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 166 | 235 | 32 | $138K |
| Epogen Epoetin Alfa | 131 | 133 | 19 | $54K |
| Dapagliflozin Dapagliflozin Propanediol | 126 | 128 | 36 | $63K |
| Auryxia Ferric Citrate | 118 | 124 | 16 | $153K |
| Ezetimibe Generic | 103 | 147 | 15 | $767 |
| Metformin Hcl Generic | 103 | 208 | 33 | $471 |
Brand drugs: 3,198 claims; generic drugs: 2,109 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karla I Menjivar $12K ($12K in general payments such as food, travel and fees) from 25 companies. The largest payer was Amgen Inc. with $10K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 64 | $10K |
| Novartis Pharmaceuticals Corporation NVS | 15 | $205 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $186 |
| Novo Nordisk Inc NVO | 8 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $150 |
| Calliditas Therapeutics US Inc. | 6 | $139 |
| Ardelyx, Inc. ARDX | 4 | $119 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $87.56 |
| Mallinckrodt Hospital Products Inc. | 3 | $72.65 |
| Fresenius USA Marketing, Inc. | 3 | $71.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.